Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Iopromide Injection

Approved

化学药品

Iopromide Injection

Bayer Vital GmbH🇨🇳 National Medical Products Administration

Approval Date: Jul 18, 2022
Approval ID: 8IbKCOVBlOW
Company: Bayer Vital GmbH
Type: 化学药品

Approval Details

Approval Id: 8IbKCOVBlOW
Approval Number: 国药准字HJ20171330
Generic Name: 碘普罗胺注射液
Generic Name En: Iopromide Injection
Trade Name: 优维显
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 100ml:62.34g
Reg Date: 2022-07-18
Expired Date: 2027-07-17
Company Name: Bayer Vital GmbH
Production Company Name: BAYER AG
Company Detail Path: /organization/bayer-vital-gmbh
Production Company Detail Path: /organization/bayer-ag

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 18, 2022

Approval ID

8IbKCOVBlOW

Type

化学药品

Back to NMPA Approvals

优维显 - NMPA Drug Approval Details